Data News > IOVA, IART, SNY, VERV, GTY showing five-day downward plunge
IOVA is trading DOWN for the last 4 days, and it at trading at $8.77 with volume of 2,012,103 and a one day change of $-0.20 (-2.18%). Iovance Biotherapeutics Inc has a 52-week low of 3.21 and a 52-week high of $18.33. The business's 50-day moving average price is $8.31 and its 200 day moving average price is $10.88. The firm has a market cap of $3 million, a P/E ratio of 0.00, and a beta of 0.63.
An analyst from Piper Sandler recently downgraded Iovance Biotherapeutics and lowered the firm's price target on the stock The FDA approved Iovance's first drug in February, and investors still aren't sure if its commercial launch can succeed. An ongoing clinical trial could greatly expand the addressable patient population for the company's lead drug.
For more information on IOVA:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
IART is trading DOWN for the last 4 days, and it at trading at $24.07 with volume of 546,535 and a one day change of $-0.96 (-3.84%). Integra Lifesciences Holdings Corp has a 52-week low of 22.36 and a 52-week high of $46.09. The business's 50-day moving average price is $29.59 and its 200 day moving average price is $33.53. The firm has a market cap of $2 million, a P/E ratio of 50.96, and a beta of 1.11.
For more information on IART:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
SNY is trading DOWN for the last 4 days, and it at trading at $51.64 with volume of 345,148 and a one day change of $-0.06 (-0.11%). Sanofi has a 52-week low of 42.63 and a 52-week high of $55.72. The business's 50-day moving average price is $49.60 and its 200 day moving average price is $48.69. The firm has a market cap of $130 million, a P/E ratio of 25.40, and a beta of 0.41.
Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's record demand for Dupixent, state of drug innovation in Europe, company outlook, and more.
For more information on SNY:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
VERV is trading DOWN for the last 4 days, and it at trading at $6.87 with volume of 187,178 and a one day change of $-0.15 (-2.14%). Verve Therapeutics Inc has a 52-week low of 4.59 and a 52-week high of $21.04. The business's 50-day moving average price is $5.73 and its 200 day moving average price is $9.29. The firm has a market cap of $1 million, a P/E ratio of 0.00, and a beta of 1.83.
For more information on VERV:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
GTY is trading DOWN for the last 4 days, and it at trading at $29.82 with volume of 177,725 and a one day change of $-0.28 (-0.93%). Getty Realty Corp. has a 52-week low of 25.70 and a 52-week high of $32.57. The business's 50-day moving average price is $28.15 and its 200 day moving average price is $27.50. The firm has a market cap of $2 million, a P/E ratio of 23.89, and a beta of 0.92.
For more information on GTY:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
IOVA, IART, SNY, VERV, GTY showing five-day downward plunge
By KlickAnalytics Data Insights | July 31, 2024 10:47AM ET
Iovance Biotherapeutics Inc (IOVA)
IOVA is trading DOWN for the last 4 days, and it at trading at $8.77 with volume of 2,012,103 and a one day change of $-0.20 (-2.18%). Iovance Biotherapeutics Inc has a 52-week low of 3.21 and a 52-week high of $18.33. The business's 50-day moving average price is $8.31 and its 200 day moving average price is $10.88. The firm has a market cap of $3 million, a P/E ratio of 0.00, and a beta of 0.63.
Top news headlines for IOVA
For more information on IOVA:
Integra Lifesciences Holdings Corp (IART)
IART is trading DOWN for the last 4 days, and it at trading at $24.07 with volume of 546,535 and a one day change of $-0.96 (-3.84%). Integra Lifesciences Holdings Corp has a 52-week low of 22.36 and a 52-week high of $46.09. The business's 50-day moving average price is $29.59 and its 200 day moving average price is $33.53. The firm has a market cap of $2 million, a P/E ratio of 50.96, and a beta of 1.11.
For more information on IART:
Sanofi (SNY)
SNY is trading DOWN for the last 4 days, and it at trading at $51.64 with volume of 345,148 and a one day change of $-0.06 (-0.11%). Sanofi has a 52-week low of 42.63 and a 52-week high of $55.72. The business's 50-day moving average price is $49.60 and its 200 day moving average price is $48.69. The firm has a market cap of $130 million, a P/E ratio of 25.40, and a beta of 0.41.
Top news headlines for SNY
For more information on SNY:
Verve Therapeutics Inc (VERV)
VERV is trading DOWN for the last 4 days, and it at trading at $6.87 with volume of 187,178 and a one day change of $-0.15 (-2.14%). Verve Therapeutics Inc has a 52-week low of 4.59 and a 52-week high of $21.04. The business's 50-day moving average price is $5.73 and its 200 day moving average price is $9.29. The firm has a market cap of $1 million, a P/E ratio of 0.00, and a beta of 1.83.
For more information on VERV:
Getty Realty Corp. (GTY)
GTY is trading DOWN for the last 4 days, and it at trading at $29.82 with volume of 177,725 and a one day change of $-0.28 (-0.93%). Getty Realty Corp. has a 52-week low of 25.70 and a 52-week high of $32.57. The business's 50-day moving average price is $28.15 and its 200 day moving average price is $27.50. The firm has a market cap of $2 million, a P/E ratio of 23.89, and a beta of 0.92.
For more information on GTY:
This article was generated by KlickAnalytics data insight content engine.
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.